Schreiner MediPharm introduces innovative first-opening indication for Prefilled Syringes

  • Schreiner MediPharm

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new tamper-evident security concept for luer-lock syringes. Schreiner MediPharm’s Cap-Lock features a combination of a cap adapter and label that firmly seals prefilled syringes for reliable first opening indication. The solution therefore ensures the primary container’s integrity by preventing undetected opening of the cap.

Cap-Lock is a specially constructed plastic cap adapter precisely placed atop a syringe’s primary closure to equalize any difference in diameter between the syringe body and closure. Then, a label with integrated perforation for tamper evidence is applied that wraps around the syringe body and the bottom part of the cap adapter. When a user opens the syringe cap, the label is partially destroyed – clearly and irreversibly indicating that the cap has been opened. This enables the user to quickly and intuitively discern any possibility of product tampering, protecting patients against administration of potentially counterfeit substances.

Using Cap-Lock in everyday healthcare settings is particularly easy, intuitive and safe: The syringe can be opened as usual and, due to the larger diameter, the adapter is simple to twist off even with gloves.

Cap-Lock from Schreiner MediPharm can be applied to syringes in a conventional production setting. Compared to shrink-wrap solutions, the application process requires no heat, making Cap-Lock also suitable for sensitive substances. The label can be provided with additional functionalities such as counterfeit-proof features, detachable documentation labels or light protection. The solution is adaptable to many commonly used syringe sizes, and both the label and adapter can be customized for color and design. Due to the combination of the adapter with the primary closure of the syringe, no additional waste is generated because both parts are firmly connected to each other.

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Jo Webb
  • Product Info
  • English
  • Created 18 Sep 2019
  • Modified 18 Sep 2019
  • Hits 176